Risk Factors for Recurrence of Clostridium difficile Infection: Effect of Vancomycin-resistant Enterococci Colonization

被引:35
作者
Choi, Hee Kyoung [1 ]
Kim, Kye Hyung [1 ]
Lee, Sun Hee [1 ]
Lee, Su Jin [1 ]
机构
[1] Pusan Natl Univ, Sch Med, Med Res Inst, Dept Internal Med,Div Infect Dis, Pusan, South Korea
关键词
Clostridium difficile; Recurrence; Risk factors; VRE; ORAL METRONIDAZOLE; DIARRHEA; DISEASE; EPIDEMIOLOGY; CONTAMINATION; PROTECTION; OUTBREAK; COLITIS; FAECIUM;
D O I
10.3346/jkms.2011.26.7.859
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recurrent Clostridium difficile infection (CDI) is one of the most difficult problems in healthcare infection control. We evaluated the risk factors associated with recurrence in patients with CDI. A retrospective cohort study of 84 patients with CDI from December 2008 through October 2010 was performed at Pusan National University Yangsan Hospital. Recurrence occurred in 13.1% (11/84) of the cases and in-hospital mortality rate was 7.1% (6/84). Stool colonization with vancomycin-resistant enterococci (VRE) (P = 0.006), exposure to more than 3 antibiotics (P = 0.009), low hemoglobin levels (P = 0.025) and continued use of previous antibiotics (P = 0.05) were found to be more frequent in the recurrent group. Multivariate analysis indicated that, stool VRE colonization was independently associated with CDI recurrence (odds ratio, 14.519; 95% confidence interval, 1.157-182.229; P = 0.038). This result suggests that stool VRE colonization is a significant risk factor for CDI recurrence.
引用
收藏
页码:859 / 864
页数:6
相关论文
共 30 条
[1]   Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease [J].
Al-Nassir, Wafa N. ;
Sethi, Ajay K. ;
Li, Yuejin ;
Pultz, Michael J. ;
Riggs, Michelle M. ;
Donskey, Curtis J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (07) :2403-2406
[2]   Treatment of Clostridium difficile-associated disease:: old therapies and new strategies [J].
Aslam, S ;
Hamill, R ;
Musher, DM .
LANCET INFECTIOUS DISEASES, 2005, 5 (09) :549-557
[3]   OUTBREAK OF MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH TRANSFERABLE VANB CLASS VANCOMYCIN RESISTANCE [J].
BOYCE, JM ;
OPAL, SM ;
CHOW, JW ;
ZERVOS, MJ ;
POTTERBYNOE, G ;
SHERMAN, CB ;
ROMULO, RLC ;
FORTNA, S ;
MEDEIROS, AA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1148-1153
[4]  
Byun Tae Jun, 2009, Korean J Gastroenterol, V54, P13
[5]   Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection [J].
Cadena, Jose ;
Thompson, George R., III ;
Patterson, Jan E. ;
Nakashima, Brandy ;
Owens, Aaron ;
Echevarria, Kelly ;
Mortensen, Eric M. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (04) :350-355
[6]   Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea [J].
Chang, Ju Young ;
Antonopoulos, Dionysios A. ;
Kalra, Apoorv ;
Tonelli, Adriano ;
Khalife, Walid T. ;
Schmidt, Thomas M. ;
Young, Vincent B. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (03) :435-438
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].
Cohen, Stuart H. ;
Gerding, Dale N. ;
Johnson, Stuart ;
Kelly, Ciaran P. ;
Loo, Vivian G. ;
McDonald, L. Clifford ;
Pepin, Jacques ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455
[9]   Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci [J].
Drees, Marci ;
Snydman, David R. ;
Schmid, Christopher H. ;
Barefoot, Laurie ;
Hansjosten, Karen ;
Vue, Padade M. ;
Cronin, Michel ;
Nasraway, Stanley A. ;
Golan, Yoav .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (08) :709-715
[10]   Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial [J].
Fekety, R ;
McFarland, LV ;
Surawicz, CM ;
Greenberg, RN ;
Elmer, GW ;
Mulligan, ME .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) :324-333